| Literature DB >> 34963369 |
Leanne Tyson1, Wendy Hardeman1, Malcolm Marquette2, Joanna Semlyen1, Gareth Stratton3, Andrew M Wilson1.
Abstract
Physical activity is promoted in the asthma population through pulmonary rehabilitation, but limited funding and facilities are available. This review aimed to examine the effectiveness of interventions that promote physical activity and identify the behaviour change techniques (BCTs) and other intervention components used. Five databases were searched, and 25 studies met the inclusion criteria. Interventions had a significant positive effect on physical activity, sedentary behaviour, quality of life and asthma symptoms. BCTs used across intervention and control groups were similar in studies that showed effects and those that did not. Future interventions should employ techniques that help to maintain behaviour change.Entities:
Keywords: asthma; exercise; intervention; physical activity; systematic review
Mesh:
Year: 2021 PMID: 34963369 PMCID: PMC9537443 DOI: 10.1177/13591053211059386
Source DB: PubMed Journal: J Health Psychol ISSN: 1359-1053
Study characteristics.
| Author (year) and country of study | Study design | Inclusion criteria and setting | Sample size and recruitment methods | Participant characteristics (disease severity, age, gender, ethnicity and co-morbidities) |
|---|---|---|---|---|
| Randomised study | FEV1/FVC ratio of <80% of predicted, use of
bronchodilators at least once daily, and symptoms of
wheezing and/or coughing for a minimum of 2-years that
improves either spontaneously or with drug
therapy. | Mild/moderate asthma. | ||
| Randomised study | Persistent asthma (as defined by the NAEPP guidelines) with
at least 12% FEV1 reversibility. | Mild/moderate asthma. | ||
| Randomised study | Diagnosis for at least 6-months, under regular drug therapy
and clinically stable during the run-in
period. | Moderate/severe asthma. | ||
| Quasi-experimental | Current prescription for asthma mediation and were
physically inactive as per the Canadian PA
Guidelines. | Partially controlled asthma. | ||
| Non-randomised study | Current prescription for asthma medication and were
physically inactive as defined by the Canadian PA
Guidelines. | Partially controlled asthma. | ||
| Randomised study | Body mass index <35 kg/m2, sedentary
(<60 minutes of physical activity/week during leisure
time), under medical treatment for at least 6-months, and
clinically stable (i.e., no crises or changes in medication
for >30 days). | Moderate/severe asthma. | ||
| Randomised study | Inclusion criteria NR. | Moderate/severe asthma. | ||
| Randomised study | Outpatients with a BMI greater than or equal to 35 and less
than 40 kg/m2, who were under optimum medical treatment,
clinically stable, and physically inactive. | Moderate/severe asthma. | ||
| Randomised study | Outpatients with grade II obesity, receiving optimal medical
treatment for at least 6-months, were clinically stable and
performed <60 minutes of structured or planned PA per
week. | Moderate/severe asthma. | ||
| Randomised Study | Under outpatient medical treatment for at least 6-months and
demonstrate clinical stability (without hospitalisation
episodes or need for emergency care for, at least
30-days). | Moderate/severe asthma. | ||
| Before-and-after study | Asthma which was being medically managed daily or on an ‘as
needed’ basis. | Mixed asthma severities. | ||
| Before-and-after study | Inclusion criteria NR. | Moderate/severe asthma. | ||
| Randomised study | BMI greater than or equal to 30 kg/m2, and confirmation of
uncontrolled persistent asthma through a multistage
screening process. | Uncontrolled Asthma. | ||
| Randomised study | Mild/moderate asthma and speak English. | Mild/Moderate Asthma. | ||
| Randomised study | Mild/moderate asthma, speak English, access to a telephone,
no limitations in mobility, and no other respiratory or
major comorbidity. | Mild/moderate asthma. | ||
| Randomised study | Under medical treatment for > 6 months and considered
clinically stable. | Moderate/severe asthma. | ||
| Randomised study | Under medical treatment for > 6 months and considered
clinically stable. | Moderate/severe asthma. | ||
| Feasibility study | Self-identified as African American and female, registered
as a patient at the medical centre, were low-active as
defined by self-report of <150 minutes of MVPA per week
and had sub-optimally controlled asthma. | Uncontrolled Asthma. | ||
| Before and after study | Non-smoking, moderately active with a current prescription
for a short-acting bronchodilator. | Mixed asthma severities. Mean (SD) = 22.5 (3.2) Years. 45% Male. 55% Female. | ||
| Non-randomised study | Adults diagnosed asthma. | Moderate/severe asthma. Age Range 20–45 Years. 44% Male. 56% Female. | ||
| Randomised study | Diagnosis for at least 6-months, taking at least one of the
following: inhaled B-agonists, methylxanthines,
anticholinergics, inhaled corticosteroid, leukotriene
inhibitors or receptor antagonists, or mast cell-stabilising
agents for at least 6-months and stable medication dosing
for the past month. | Mild/moderate asthma. | ||
| Randomised Study | Inclusion criteria NR. | |||
| Randomised study | Body mass index of more than 20 and less then 30 kg/m, and
ACQ score of 1.0 or more, and at least one positive
diagnostic test demonstrating variable airflow obstruction.
Should either have been on a stable prophylactic treatment
regime with inhaled corticosteroids (ICSs), ICS +
long-acting beta1-agonsit, and/or leukotriene antagonist or
have had no prophylactic treatment at least 3-months before
enrolment. | Age Range 18–65 Years. 31% Male. 69% Female. | ||
| Randomised study | Diagnosis for at least 6-months, taking at least one of the
following anthines, anticholinergics and/or inhaled
corticosteroids, and stable medication dosing for the past
month. | Mild/moderate asthma. | ||
| Randomised study | Inclusion criteria NR. | Mild/moderate asthma. |
FEV/FVC: forced expiratory volume in 1-second/forced vital capacity; NR: not reported; PA: physical activity; MVPA: moderate-vigorous physical activity; ACQ: asthma control questionnaire.
Intervention characteristics and behavioural outcomes.
| Author (year) and country of study | Description of intervention and comparator group(s) | Intervention length and intensity | Intervention provider(s) and mode and focus of delivery | Behavioural
outcome(s) | |
|---|---|---|---|---|---|
| Measurement tool | Intervention effect | ||||
| IG: Unsupervised pedometer-based programme. PA
subscription, consisting of targets calculated
weekly. | ⩽3 months | Physiotherapist(s). | PA: Pedometer. | PA: Statistically sig difference in daily steps
between-groups ( | |
| IG: Education and aerobic exercise training programme,
performed on an indoor treadmill. | ⩽3 months. | Care providers, teams, or centres performing the
intervention. | PA: Accelerometer. | PA: Changes between-groups were not sig
( | |
| WL+E: Weight-loss programme incorporating aerobic and
resistance muscle training. | ⩽3 months. | Nutritionist(s), psychologist(s) and
physiotherapist(s). | PA: Accelerometer. | PA: IG demonstrated a sig increase in daily life PA
levels compared to the CG
( | |
| WL+E: Weight-loss programme incorporating aerobic and
resistance muscle training. | ⩽3 months. | Nutritionist(s), psychologist(s) and
physiotherapist(s). | PA: Accelerometer. | PA: IG demonstrated a sig increase in daily step count
( | |
| Received tailored walking prescription and pedometer (optional walking sessions), asthma education session, written materials on exercise with asthma, group discussions to address goals and barriers, and motivational telephone calls and text messaging. | ⩽3 months. | Intervention provider(s) NR. | PA: Accelerometer and | PA: Small, but not sig negative effect on step count and
positive effect on MVPA
( | |
| IG: Lifestyle intervention, dually targeting modest
weight-loss and increased PA. | ⩽12 months. | Intervention provider(s) NR. | PA: Stanford 7-Day PA Interview. | PA: Sig between-group difference in change of
leisure-time physical activity and total daily energy
expenditure ( | |
| IG: Contract to increase PA and received a pedometer and
an asthma workbook. Received | ⩽12 months. | Intervention provider(s) NR. | PA: Puffenarger PA and Exercise Index. | PA: Energy expenditure significantly increased in the CG
( | |
| IG: Contract to increase PA and received a pedometer and
an asthma workbook. Received | ⩽12 months. | Intervention provider(s) NR. | PA: Puffenarger PA and Exercise Index. | PA: Energy expenditure increased by a clinically
important change in both groups
( | |
| IG: Training programme, consisting of a warm-up and
between one and four circuits of seven
exercises. | ⩽3 months. | Intervention provider(s)
NR. | PA: Life in New Zealand Survey. | PA: Two variables were found to be significantly higher
following training in both groups
( | |
| EG: Aerobic and resistance training. Received a 12-week
gym membership and personal training session and
educational materials regarding national PA
recommendations. | ⩽3 months. | Nutritionist(s), psychologist(s) and
physiotherapist(s). | PA: International PA Questionnaire. | PA: EG demonstrated a sig increase in PA
( | |
IG: intervention group; PA: physical activity; CG: control group; p/w: per week; sig: significant; SB: sedentary behaviour; WL+E: weight-loss and exercise; WL+S: weight-loss and sham; MVPA: moderate-vigorous physical activity; MPA: moderate physical activity; p/d: per day; PEFE: peak expiratory flow; EG: exercise group; DG: diet group; E/DG: exercise and diet group; NR: not reported.
Intervention characteristics and health outcomes.
| Author (year) and country of study | Description of intervention and comparator group(s) | Intervention length and intensity | Intervention provider(s) and mode and focus of delivery | Health outcome(s) | |
|---|---|---|---|---|---|
| Measurement tool | Intervention effect | ||||
| IG: Supervised yoga training session. Required to
perform written lesson plans at home. | ⩽3 months. | Certified yoga
instructor(s). | QoL: SGRQ. | QoL: IG significantly improved compared to the CG, who
showed no improvements
( | |
| IG: Walking programme exercising at 60%–75% of MRmax and
brief education. Received 3-month free gym
membership. | ⩽3 months. | Intervention provider(s)
NR. | AC: ACQ. | AC: Changes between-groups were not sig
( | |
| IG: Unsupervised pedometer-based programme. PA
subscription, consisting of targets calculated
weekly. | ⩽3 months | Physiotherapist(s). | AC: ACQ. | AC: Changes between-groups were not sig
( | |
| IG: Self-directed individualised exercise programme.
Sent pictures and descriptions of strength and
stretching exercises, modified every 3-weeks. | ⩽3 months. | Exercise
specialist(s). | AC: ACQ. | AC: Changes between-groups were not sig
( | |
| IG: Exercise training followed by a period of prescribed
self-administered exercise. | ⩽6 months. | Exercise
specialist(s). | AC: ACQ. | AC: ACQ without spirometry significantly improved in the
IG compared to the CG
( | |
| IG: Education and aerobic exercise training programme,
performed on an indoor treadmill. | ⩽3 months. | Care providers, teams, or centre preforming the
intervention. | AC: ACQ. | AC: IG demonstrated a sig decrease in scores
( | |
| IG: Education, breathing exercise and aerobic training
programme, completed on an indoor treadmill. | ⩽3 months. | Physiotherapist(s). | AC: ACQ. | AC: Changes between-groups were not sig
( | |
| WL+E: Weight-loss programme incorporating aerobic and
resistance muscle training. | ⩽3 months. | Nutritionist(s), psychologist(s) and
physiotherapist(s). | AC: ACQ. | AC: Scores significantly improved in the IG compared to
the CG ( | |
| WL+E: Weight-loss programme incorporating aerobic and
resistance muscle training. | ⩽3 months. | Nutritionist(s), psychologist(s) and
physiotherapist(s). | Symptoms: Daily Diary. | Symptoms: IG had a sig increase in the number of
asthma-free days, compared to the CG
( | |
| IG: Education and respiratory exercise programme.
Submitted to aerobic training on a treadmill. | ⩽3 months. | Intervention provider(s)
NR. | QoL: EPM Questionnaire. | QoL: IG significantly improved in the following domains:
physical limitations, frequency of symptoms,
psychosocial limitations, and the total score
( | |
| Aquatic exercise programme. | ⩽3 months. | Swimming
Instructor(s). | QoL: AIS and a 7-question survey. | QoL: Changes within-group were not sig
( | |
| Admitted to hospital for a period of 40-days. Given vegetarian diet and daily yoga training. | ⩽3 months. | Intervention provider(s) NR. | Symptoms: MRC Dyspnoea Scale. | Symptoms: 18 patients initially with moderate-severe asthma remained asymptomatic for 1-year. | |
| IG: Lifestyle intervention, dually targeting modest
weight-loss and increased PA. | ⩽12 months. | Intervention provider(s) NR. | AC: ACQ and ACT. | AC: Changes between-groups were not sig at 6-months
( | |
| IG: Contract to increase PA and provided with a
pedometer and an asthma workbook.
Received | ⩽12 months. | Intervention provider(s) NR. | AC: ACQ. | AC: IG significantly improved from 1.43 to 0.83
( | |
| IG: Aerobic training programme. Received an educational
programme and taught yoga breathing
exercises. | ⩽3 months. | Intervention provider(s)
NR. | QoL: Simplified AQLQ. | QoL: Sig improvements in the physical limitations,
frequency of symptoms, psychosocial domains and total
score occurred only in the IG
( | |
| IG: Aerobic training programme. Received an educational
programme and taught yoga breathing
exercises. | ⩽3 months. | Intervention provider(s)
NR. | Symptoms: Daily Diary. | Symptoms: IG showed a sig increase in the number of
symptom-free days after 30-days
( | |
| High-intensity interval training. | ⩽3 months. | Intervention provider(s)
NR. | AC: ACQ. | AC: Sig improvements were observed when comparing pre-
and post-intervention sessions
( | |
| IG: Training programme, consisting of a warm-up and
between one and four circuits of seven
exercises. | ⩽3 months. | Intervention provider(s)
NR. | Medication Usage: Daily Diary. | Medication Usage: No sig changes
( | |
| IG: Yoga training programme. Provided with printed
materials and audiocassettes and encouraged to practice
at home. | ⩽3 Months. | Exercise specialist(s). | QoL: Mini-AQLQ. | QoL: Changes between-groups were not sig
( | |
| EG: Aerobic and resistance training. Received a 12-week
gym membership and personal training session and
educational materials regarding national PA
recommendations. | ⩽3 months. | Nutritionist(s), psychologist(s) and
physiotherapist(s). | AC: ACQ. | AC: No sig improvement in the EG
( | |
| EG: High-intensity interval training. | ⩽3 Months. | Trained spinning instructor(s) and
dietician(s). | AC: ACQ. | AC: Sig within-group improvements in all treatment
groups, but when compared to the CG only E/DG had
statistically sig improvements
( | |
| IG: Yoga-based lifestyle modification and stress
management programme. Provided with printed materials,
audiocassettes and telephonic support. | ⩽3 Months. | Qualified yoga instructor(s) and
physician(s). | QoL: AQLQ. | QoL: Significantly improved in both groups but achieved
earlier in the IG
( | |
| IG: Yoga training. Received audio cassettes and written
information to continue practising at home. | ⩽6 Months. | Trained yoga
teacher(s). | Medication Usage: NR. | Medication Usage: Changes between-groups were not sig
( | |
IG: intervention group; CG: control group; p/w: per week; QoL: quality of life; SGRQ: St Georges quality of life questionnaire; HRmax: maximum heart rate; NR: not reported; AC: asthma control; ACQ: asthma control questionnaire; AQLQ: asthma quality of life questionnaire; AIS: asthma impact survey; PA: physical activity; WL+E: weight-loss and exercise; WL+S: weight-loss and sham; MRC: medical research council; ACT: asthma control test; p/d: per day; EG: exercise group; DG: diet group; E/DG: exercise and diet group.